inositol d-chiro-inositol
Selected indexed studies
- D-Chiro-inositol and PCOS: between myth and reality. The never-ending story. (Int J Food Sci Nutr, 2022) [PMID:35057707]
- Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. (Nutrients, 2023) [PMID:37111094]
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome. (Gynecol Endocrinol, 2024) [PMID:38239032]
_Worker-drafted node — pending editorial review._
Connections
inositol d-chiro-inositol helps
Sources
- Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. (2023) pubmed
- D-Chiro-inositol and PCOS: between myth and reality. The never-ending story. (2022) pubmed
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome. (2024) pubmed
- From Myo-inositol to D-chiro-inositol molecular pathways. (2021) pubmed
- Myo-inositol vs. D-chiro inositol in PCOS treatment. (2015) pubmed
- Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study. (2022) pubmed
- The use of D-chiro-Inositol in clinical practice. (2021) pubmed
- The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. (2019) pubmed
- Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. (2017) pubmed
- The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria. (2024) pubmed